Table 2.
Baseline socio-demographic and clinical characteristics of study participants.
| Characteristics at Baseline | RT (n = 19) | MAIR (n = 22) | (p) |
|---|---|---|---|
| Socio-demographics | |||
| Sex, female | 19 (100) | 22 (100) | − |
| Age | 52.21 (5.95) | 52.77 (13.45) | 0.86 |
| Marital status, stable relationship | 13 (68.4) | 12 (54.5) | 0.39 |
| Residence, urban | 19 (100) | 22 (100) | 0.27 |
| Dwelling, own home | 17 (89.5) | 18 (81.8) | 0.76 |
| Education | 0.66 | ||
| Primary | 4 (21.1) | 7 (31.8) | |
| Secondary | 8 (42.1) | 8 (36.4) | |
| University | 7 (36.8) | 7 (31.8) | |
| Employment | 0.43 | ||
| Employed | 5 (26.2) | 3 (13.6) | |
| Sick leave/inability | 8 (42.2) | 8 (36.4) | |
| Unemployed | 6 (31.6) | 11 (50.0) | |
| Clinical measures | |||
| Fibromyalgia impact | |||
| FIQ (0–100) | 62.83 (18.41) | 70.61 (17.21) | 0.17 |
| Clinical severity | |||
| CGI-S (1–7) | 4.32 (1.16) | 4.59 (1.14) | 0.45 |
| Pain catastrophizing | |||
| PCS (0–52) | 25.00 (10.92) | 29.50 (9.73) | 0.17 |
| Anxiety and depression | |||
| HADS-A (0–21) | 11.37 (5.40) | 12.32 (3.48) | 0.52 |
| HADS-D (0–21) | 8.05 (6.03) | 9.73 (5.19) | 0.35 |
| Perceived health | |||
| EQ-VAS (0–100) | 54.00 (20.19) | 48.18 (17.01) | 0.32 |
| Psychological inflexibility | |||
| AAQ-II (10–70) | 37.32 (13.34) | 41.00 (10.45) | 0.33 |
| Mindfulness facets | |||
| FFMQ (39–195) | 118.74 (14.96) | 116.32 (18.48) | 0.65 |
| Self-compassion | |||
| SCS (6–30) | 16.81 (4.13) | 16.63 (3.81) | 0.89 |
| Taking pharmacological treatment | |||
| Non-opioid analgesics | 2 (10.5) | 3 (13.6)) | 0.76 |
| Opioids | 2 (10.5) | 4 (18.2) | 0.49 |
| NSAIDs | 2 (10.5) | 2 (9.1) | 0.88 |
| Antidepressants | 2 (10.5) | 8 (36.4) | 0.06 |
| Anticonvulsants | 2 (10.5) | 4 (18.2) | 0.49 |
| Benzodiazepines | 6 (31.6) | 5 (22.7) | 0.52 |
| Antipsychotics | 0 (0.0) | 1 (4.5) | 0.35 |
| Total number of medications | 0.84 (0.96) | 1.23 (0.97) | 0.21 |
FIQ: Fibromyalgia Impact Questionnaire; CGI-S: Clinical Global Impression Severity Scale; PCS: Pain Catastrophizing Scale; HADS-A: Hospital Anxiety and Depression Scale-Anxiety; HADS-D: Hospital Anxiety and Depression Scale-Depression; EQ-5D-VAS: Visual Analogue Scale from EuroQol; AAQ-II: Acceptance and Action Questionnaire. FFMQ: Five Facets of Mindfulness Questionnaire; SCS: Self-Compassion Scale; NSAIDs: non-steroidal anti-inflammatory drugs.